Consolidated Statements of Comprehensive Loss Parentheticals - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Consolidated Statements of Operations [Abstract] | ||||
Stock-based compensation expense associated with research and development expense | $ 939 | $ 1,138 | $ 3,069 | $ 3,608 |
Stock-based compensation expense associated with selling, general and administrative expense | $ 1,709 | $ 1,574 | $ 5,183 | $ 4,741 |